The 2026 LBCA Lobular Breast Cancer Awareness Tour hits the road Sept. 26th. Check out the updated itinerary and event details for each stop across more than 15 cities:https://lobularbreastcancer.org/awareness-day/ #ilcawarenesstour #ILC #lobularbreastcancer #invasivelobularcarcinoma

📣 Join us October 15 at Dana-Farber, in collaboration with the @lobularbca.bsky.social, for an event bringing together patients, advocates, researchers, and clinicians to raise awareness and highlight advances in #LobularBreastCancer research and care. Register today docs.google.com/forms/d/e/1F...

LBCA PAAB member Kristen Elsby joined Pamela Kinnon and Becky Collins of the Lobular Breast Cancer Australia & New Zealand Facebook group for a Q&A with University of Queensland researchers Dr. Pete Simpson, Dr. Ros Francis and Dr. Amy McCart Reed. Watch the recording: youtu.be/KdjtZWn4Vtc

Catch up on the latest ILC research, education, advocacy, and LBCA updates, all in one place by subscribing to our newsletter. Not subscribed? Sign up here: lobularbreastcancer.org/contact-us/s...

LBCA has earned a Four-Star Charity designation from Charity Navigator! ⭐ ⭐ ⭐ ⭐ This recognition reflects our commitment to accountability, transparency, and making every donation count in advancing #ILC research, education, and advocacy. Learn more: www.charitynavigator.org/ein/862260246

Five-year survivor Famke shares her experience with lobular breast cancer and why it’s time to talk about ILC. Soon, LBCA will take that message on the road with our cross-country Awareness Tour, helping more people learn about ILC along the way. Learn more: bit.ly/ILC-Awarenes...

LBCA Executive Director Laurie Hutcheson joined State Rep. Michelle Badger on Monday Night Talk with Kevin Tocci to discuss ILC awareness, early detection, Lobular Breast Cancer Awareness Day and LBCA’s upcoming cross-country awareness raising bus tour: www.podbean.com/ew/pb-x5g25-...

LBCA recently launched a newly reorganized website! Informed by community feedback, the updated site makes it easier to navigate and find trusted, ILC-specific information and resources. Explore the website: lobularbreastcancer.org #LobularBreastCancer #InvasiveLobularCarcinoma #ILC

LBCA’s #ILC Training for Advocates is now available on demand! Developed with ILC researchers and clinicians, the curriculum covers ILC biology, treatment, imaging and surveillance. Explore the curriculum and watch the videos: lobularbreastcancer.org/ilc-training...

LBCA is pleased to welcome Cynthia Blevins Doll, Lisa Pellegrino, and Jane Rozina to our Board! They bring a range of professional expertise, leadership experience, and perspectives, along with a shared commitment to LBCA’s mission and the ILC community: lobularbreastcancer.org/lbca-welcome...

After being diagnosed with ILC, Betsy underwent chemotherapy, a bilateral mastectomy, and radiation. In her story, she reflects on her experience, discovering LBCA, and why she wishes she had known more about ILC when she was first diagnosed: lobularbreastcancer.org/my-ilc-story...

The countdown is on! In just a few weeks, LBCA's Lobular Breast Cancer Awareness Tour begins its cross-country journey to raise awareness of #ILC. Follow along, join us at a tour stop, or help spread the word: bit.ly/ILC-Awarenes... #BreastCancerAwareness #AwarenessTour

Lobular Breast Cancer FAQ: How can artifical intelligence (AI) be used to help diagnose Lobular Breast Cancer? Read more FAQs on our website: lobularbreastcancer.org/faq/ #LobularBreastCancer #InvasiveLobularCarcinoma #ILC

Congratulations to Dr. Kate Beecher Matthews, recipient of the 2026 LBCA Early Investigator ILC Research Grant! Through this $50,000, one-year grant, LBCA is investing in the next generation of ILC researchers. Her work will explore the role of SCUBE2 in ILC biology: www.conquer.org/about/news/L...

Missed the live session? Watch Session 3 of LBCA’s Liquid Biopsy webinar series on demand to learn about what a liquid biopsy is and how it is being used in the management and monitoring of metastatic invasive lobular carcinoma (mILC): youtu.be/0ndqfNBtzuo?...

Fran Visco, President of the National Breast Cancer Coalition and a 30+ year breast cancer survivor living with metastatic breast cancer, recently wrote an Op-Ed urging Congress to pass the Metastatic Breast Cancer Access to Care Act. Contact your representatives to support this bill: Congress.gov.

LBCA is launching a nationwide Lobular Breast Cancer Awareness Tour to raise awareness of invasive lobular carcinoma (ILC) and our resources for ILC patients. From Sept. 26th through Oct. 15th (Lobular Breast Cancer Awareness Day), we’ll travel cross country. Learn more: bit.ly/ILC-Awarenes...

LBCA advocates are raising awareness of #ILC in communities across the country. Through local events and health fairs, advocates are sharing resources and stories to help more people understand what makes ILC different from other breast cancers. Get involved: LATadmin@lbca.org

The University of Colorado Anschutz Cancer Center has launched the Lobular Breast Cancer Initiative, led by LBCA Scientific Advisory Board member Dr. Matthew Sikora, to advance #ILC research and improve patient care: lobularbreastcancer.org/new-ilc-focu...

The Lobular American Research Consortium (LARC), the first investigator-led U.S. research consortium dedicated exclusively to invasive lobular carcinoma (ILC), has officially launched. Learn more about how LARC will accelerate collaboration and advance research: bit.ly/4yWXRtR #ILC

The Lobular American Research Consortium (LARC), the first investigator-led U.S. research consortium dedicated exclusively to invasive lobular carcinoma (ILC), has officially launched. Learn more about how LARC will accelerate collaboration and advance research: bit.ly/4yWXRtR #ILC

LBCA Scientific Advisory Board member Dr. George Sflomos recently shared insights into his research on LOX inhibition and its role in disrupting pathways involved in the progression of metastatic ILC tumors, as well as what this work may mean for the future research. Learn more: bit.ly/4pFqAPw

Diagnosed with invasive lobular carcinoma (ILC) in her late 30s, Famke shares her journey from diagnosis to survivorship and the importance of self-advocacy, research, and reliable information about lobular breast cancer. Read more: bit.ly/3TabchY#Inva... #ILC

LBCA and SNMMI are accepting applications for a $100,000 Invasive Lobular Carcinoma Imaging Research Grant to support innovative #ILC imaging research. Applications are due August 14. Apply here: lnkd.in/e6rhZan3

We're excited to welcome Mary Pat Landry to the LBCA Board of Directors! After her 2022 invasive lobular carcinoma (ILC) diagnosis, Mary Pat found support through LBCA and is now helping advance our mission. Learn more about our Board of Directors: lobularbreastcancer.org/board-of-dir...

A new clinical trial testing efficacy of a drug to treat metastatic ILC is now enrolling. Led by LBCA Scientific Advisory Board Chair Dr. Jason Mouabbi, the IvoLoC Trial will advance knowledge of options for personalized treatment approaches for people living with metastatic ILC. 🔗 bit.ly/4fk9XoY

Join LBCA on Wednesday, July 29 at 3:00 p.m. ET for our third Liquid Biopsy webinar. Hear from leading experts on the latest research and what's next. Register: us02web.zoom.us/webinar/regi... #lobularbreastcancer #invasivelobularcarcinoma #ILC

This month we show our gratitude to LBCA Board of Directors member, Irene Jamieson, for her generous donation of this year’s volunteer appreciation gift. Irene has been a valuable, longtime supporter of LBCA with both her time and gifts and we are so thankful for her continued generosity!

Two LBCA SAB Members made the news, Dr. Ulaner was elected President of SNMMI and Dr. Kruse was interviewed in on clinical trials. lobularbreastcancer.org/sab-members-...

LBCA’s fourth Local Advocacy Team (LAT) has launched in Michigan! It will be run by LAT Ambassadors Valerie Frasier and Ciara Mohan Gustafson. Learn more and about how you can get involved: lobularbreastcancer.org/michigan_LAT/ #lobularbreastcancer #invasivelobularcarcinoma #ILC #LBCALAT